Seres Therapeutics (MCRB) Insider Trading & Ownership → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free MCRB Stock Alerts $0.82 +0.08 (+10.74%) (As of 04/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Seres Therapeutics (NASDAQ:MCRB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$83,463.48 Get MCRB Insider Trade Alerts Want to know when executives and insiders are buying or selling Seres Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MCRB Insider Buying and Selling by Quarter Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! Seres Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/16/2024David ArkowitzCFOSell3,939$1.08$4,254.12 2/16/2024Eric D ShaffCEOSell11,549$1.08$12,472.92 2/16/2024Teresa L YoungInsiderSell3,374$1.08$3,643.92 10/30/2023David ArkowitzCFOSell4,066$1.35$5,489.10 10/30/2023Eric D ShaffCEOSell8,552$1.35$11,545.20 10/30/2023Paula CloghessyInsiderSell2,904$1.35$3,920.40 10/30/2023Thomas DesrosierEVPSell4,156$1.35$5,610.60 4/28/2023David S EgeInsiderSell7,038$5.19$36,527.22 (Data available from 1/1/2013 forward) MCRB Insider Trading Activity - Frequently Asked Questions Who is on Seres Therapeutics's Insider Roster? The list of insiders at Seres Therapeutics includes David Arkowitz, David S Ege, Eric D Shaff, Health Ltp Fund Ge Nutritional, Paula Cloghessy, Teresa L Young, and Thomas Desrosier. Learn more on insiders at MCRB. What percentage of Seres Therapeutics stock is owned by insiders? 5.10% of Seres Therapeutics stock is owned by insiders. Learn more on MCRB's insider holdings. Which Seres Therapeutics insiders have been buying company stock? The following insider purchased MCRB shares in the last 24 months: Health Ltp Fund Ge Nutritional ($27,525,465.45). How much insider buying is happening at Seres Therapeutics? Insiders have purchased a total of 8,738,243 MCRB shares in the last 24 months for a total of $27,525,465.45 bought. Which Seres Therapeutics insiders have been selling company stock? The following insiders have sold MCRB shares in the last 24 months: David Arkowitz ($9,743.22), David S Ege ($76,272.38), Eric D Shaff ($24,018.12), Paula Cloghessy ($3,920.40), Teresa L Young ($3,643.92), and Thomas Desrosier ($5,610.60). How much insider selling is happening at Seres Therapeutics? Insiders have sold a total of 50,590 Seres Therapeutics shares in the last 24 months for a total of $123,208.64 sold. More Insider Trading Tools from MarketBeat Related Companies: Oramed Pharmaceuticals Insider Ownership Genelux Insider Ownership Milestone Pharmaceuticals Insider Ownership Reviva Pharmaceuticals Insider Ownership Allakos Insider Ownership Anixa Biosciences Insider Ownership Cartesian Therapeutics Insider Ownership IO Biotech Insider Ownership DiaMedica Therapeutics Insider Ownership Emergent BioSolutions Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:MCRB) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seres Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
